167 related articles for article (PubMed ID: 9525319)
1. Expression of the human immunodeficiency virus type 1 primer binding sequence inhibits HIV-1 replication.
Kechli AM; Freiden PJ; Rossi JJ; Brenner MK; Choueiry MA; Garcia JV; Slobod KS
Hum Gene Ther; 1998 Mar; 9(4):587-90. PubMed ID: 9525319
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
3. Impact of forced selection of tRNAs on HIV-1 replication and genome stability highlight preferences for selection of certain tRNAs.
Ni N; Morrow CD
Virus Res; 2007 Mar; 124(1-2):29-37. PubMed ID: 17070952
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
[TBL] [Abstract][Full Text] [Related]
6. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
Wakefield JK; Rhim H; Morrow CD
J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
[TBL] [Abstract][Full Text] [Related]
7. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
Xu W; Morrow CD
Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
[TBL] [Abstract][Full Text] [Related]
8. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
Wakefield JK; Kang SM; Morrow CD
J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
[TBL] [Abstract][Full Text] [Related]
9. Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA(Lys) molecule in reverse transcription.
Das AT; Klaver B; Berkhout B
J Gen Virol; 1997 Apr; 78 ( Pt 4)():837-40. PubMed ID: 9129656
[TBL] [Abstract][Full Text] [Related]
10. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
Kang SM; Wakefield JK; Morrow CD
Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
[TBL] [Abstract][Full Text] [Related]
11. The nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro.
Chan B; Musier-Forsyth K
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13530-5. PubMed ID: 9391060
[TBL] [Abstract][Full Text] [Related]
12. HIV type 1 that select tRNA(His) or tRNA(Lys1,2) as primers for reverse transcription exhibit different infectivities in peripheral blood mononuclear cells.
Moore KL; Kosloff BR; Kelly NJ; Kirkman RL; Dupuy LC; McPherson S; Morrow CD
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):373-81. PubMed ID: 15157356
[TBL] [Abstract][Full Text] [Related]
13. Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus.
Das AT; Berkhout B
Nucleic Acids Res; 1995 Apr; 23(8):1319-26. PubMed ID: 7538660
[TBL] [Abstract][Full Text] [Related]
14. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).
Das AT; Klaver B; Berkhout B
J Virol; 1995 May; 69(5):3090-7. PubMed ID: 7707537
[TBL] [Abstract][Full Text] [Related]
15. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
Wakefield JK; Wolf AG; Morrow CD
J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
[TBL] [Abstract][Full Text] [Related]
17. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met).
Kang SM; Zhang Z; Morrow CD
J Virol; 1997 Jan; 71(1):207-17. PubMed ID: 8985340
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.
Beerens N; Groot F; Berkhout B
Nucleic Acids Res; 2000 Nov; 28(21):4130-7. PubMed ID: 11058109
[TBL] [Abstract][Full Text] [Related]
19. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1.
Yamada O; Yu M; Yee JK; Kraus G; Looney D; Wong-Staal F
Gene Ther; 1994 Jan; 1(1):38-45. PubMed ID: 7584058
[TBL] [Abstract][Full Text] [Related]
20. The HIV plus-strand transfer reaction: determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence.
Muthuswami R; Chen J; Burnett BP; Thimmig RL; Janjic N; McHenry CS
J Mol Biol; 2002 Jan; 315(3):311-23. PubMed ID: 11786014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
